Literature DB >> 2145016

Current management of cancer of the lip.

S R Baker1.   

Abstract

Carcinoma of the lip is the most common cancer of the oral cavity, occurring most frequently on the lower lip of elderly males. Less advanced neoplasms may be treated equally successfully by surgery or irradiation, and results are cosmetically acceptable by both methods. Reconstruction of the lip following surgical ablation of tumor usually consists of primary repair. Larger defects require flaps from the opposite lip, adjacent cheek, or more distant tissue. Although prophylactic neck dissection is usually not indicated, the presence of neck metastases from carcinoma of the lip is best managed by neck dissection followed by postoperative radiotherapy. The prognosis for curing lip cancer is dependent upon the size of the primary tumor and whether cervical metastasis has occurred. The overall five-year cure rate of lip cancer approximates 80%. The cure rate of patients with neck metastases is approximately 50%.

Entities:  

Mesh:

Year:  1990        PMID: 2145016

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

1.  Surgical management of lip cancer.

Authors:  A Moretti; F Vitullo; A Augurio; A Pacella; A Croce
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-02       Impact factor: 2.124

Review 2.  Reconstruction of the lower lip after broad oncologic resection by Colmenero flap: a reliable option.

Authors:  José-Miguel Costa-Gonzalez; Anna Sumarroca; Jordi Aguilera-Saez; María Martel-Martin; Andreas Leidinger; María-Pilar Machin; Rosa-Delia Ramirez-Ruiz
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-11-26       Impact factor: 2.124

3.  Surgical attitude in premalignant lesions and malignant tumors of the lower lip.

Authors:  N Calcaianu; S A Popescu; D Diveica; I Lascar
Journal:  J Med Life       Date:  2015 Jan-Mar

4.  Non-invasive imaging of actinic cheilitis and squamous cell carcinoma of the lip.

Authors:  Mihai Lupu; Ana Caruntu; Constantin Caruntu; Daniel Boda; Liliana Moraru; Vlad Voiculescu; Alexandra Bastian
Journal:  Mol Clin Oncol       Date:  2018-03-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.